Impact of the implementation of the Intelligent Antimicrobial System (iAMS) on clinical outcomes among patients with bacteraemia caused by methicillin-resistant Staphylococcus aureus

  15 May 2024

The study examined the impact of the Intelligent Antimicrobial System (iAMS) on patients with bacteraemia caused by methicillin-resistant and methicillin-susceptible Staphylococcus aureus (MRSA). The iAMS group showed a 5.2% increase in 1-year survival rates, while MRSA patients experienced a 17.6% and 7.0% increase in survival rates. The iAMS intervention also improved long-term survival rates, discharge rates, hospitalization days, and medical cost, while reducing near miss medication incidents. The study concluded that iAMS improved patient outcomes.

Author(s): Lu-Ching Ho et al
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed